| Name | Title | Contact Details |
|---|
The Hierarchy is a Chester, PA-based company in the Business Services sector.
Apellis Pharmaceuticals is a global biopharmaceutical company based in Waltham, Massachusetts. The company is focused on developing innovative therapies that target the complement system, a crucial part of the immune system. Apellis aims to create life-changing treatments for various debilitating diseases through its commitment to scientific research and patient care. The company has a diverse pipeline of products, including EMPAVELI, which is approved for treating paroxysmal nocturnal hemoglobinuria and is being investigated for other conditions. SYFOVRE is in development for geographic atrophy, along with a combination therapy involving APL-APL-3007. Apellis is also exploring RNA therapies and gene-edited treatments for multiple therapeutic areas. With a global presence in countries such as the US, Canada, and several European nations, Apellis serves patients and healthcare providers affected by diseases related to the complement system. The company reported approximately $709 million in U.S. net product revenues for the full year 2024, reflecting its strong market position and commitment to advancing its therapeutic offerings.
Proxonic Visuals is a Vancouver, BC-based company in the Business Services sector.
Vision Capital Partners, Inc. is a Belmont, MI-based company in the Business Services sector.
GenomOncology is a precision oncology software company based in Cleveland, Ohio, founded in 2012. The company focuses on transforming complex clinical and molecular data into actionable insights to enhance cancer care. Its mission is to empower healthcare institutions to utilize data-driven decision-making tailored to the specific needs of precision oncology programs. The core offering is the Precision Oncology Platform (POP), which integrates proprietary algorithms and machine learning to analyze genetic test results and clinical data, providing treatment recommendations and clinical trial matching. Additionally, the GO Pathology Workbench supports germline testing workflows, allowing labs to efficiently validate and report genetic findings. GenomOncology also offers data integration services that combine internal patient data with external annotation sets to generate evidence-based insights. The company primarily serves hospitals, cancer centers, and laboratories looking for scalable tools for genomic data interpretation and therapy matching.